The Leadless Pacing System Market to Be Driven By Comprehensive Care

The global Leadless Pacing System Market is estimated to grow noticeably in the next 10 years. With personalization doing the rounds, the healthcare vertical is also not expected to escape. With digitization, not just the track record of the patient but also the precautionary measures to be taken could be put forth. This would be how the healthcare vertical go about in the subsequent period.

According to the latest market report published by Persistence Market Research titled 'Leadless Pacing Systems Market: Global Industry Analysis (2012 - 2016) & Forecast (2017 - 2025),' the market is poised to expand at a CAGR of 10.0% in terms of value over the forecast period (2017-2025).

Strategizing The Moves For The Next Decade? See Through Sample Of Leadless Pacing System Market Report! https://www.persistencemarketresearch.co/samples/12205

The overall market is anticipated to grow 2.15x in terms of value over the forecast period of 2017-2025. Certain factors such as rise in the number of eligible patients, increasing reimbursement scenario, rising disposable income, preference for new technology, growing geriatric population, rising number of cardiovascular diseases and increasing number of medical insurers is expected to support market growth over the forecast period.

Company Profiles

Abbott Laboratories
Medtronic Plc

Revenue growth is also supported by several technological benefits of leadless pacing systems over traditional pacemaker systems. The report analyzes the leadless pacing systems market in terms of value (US$ Mn) by application type, end user and region.

The report also provides information regarding market dynamics, macro-economic factors, opportunity analysis, pricing analysis, regulations, competitive landscape, regional volume analysis, current trends, market estimation and forecast, technology assessment and major deals in the leadless pacing systems market.

For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/market-research/leadless-pacing-system-market/toc

Segmental Forecast

The global leadless pacing systems market is expected to exceed US$ 63.5 Mn by 2025, attesting the highest growth of the atrial fibrillation application segment, which is expected to expand at 10.1% CAGR over the forecast period. Atrial fibrillation segment will dominate the market in terms of value. In the end user segment, hospitals represent more than 85% of the market share.

In terms of value, the North America regional market holds the highest share in the global market followed by Europe. This is because of higher demand in these regions, product affordability and a favorable reimbursement scenario.

Middle East & Africa represents a significant market share in the global leadless pacing systems market given the historical acceptance in the number of procedures for leadless pacing technology over traditional pacemakers.

In terms of growth rate, Europe leads with a CAGR of 11.2% followed by Asia Pacific with an increasing product acceptance. Latin America is anticipated to have the least market size over the forecast period. The global market for leadless pacing systems is anticipated to expand at a significant growth rate over the forecast period providing good growth opportunities for market players.

How About Obtaining Insights About The Region To Enter Concerning The Leadless Pacing System Market? Press The "Purchase Now" Button To Have Our Leadless Pacing System Market Report! https://www.persistencemarketresearch.com/checkout/12205

Key Research Findings

Demand for leadless pacing systems is anticipated to remain high through 2025, registering a CAGR of 10.0% over the forecast period owing to the rising number of cardiovascular diseases and increasing pacemaker implant rate

Due to the technical advantages of leadless pacing systems, this product segment is anticipated to absorb significant market size in the single chamber ventricular pacing systems market

The higher pricing of leadless pacing systems than normal pacemakers is a major limiting factor in the leadless pacing systems market

There are only two companies with their products commercially approved by regulatory bodies while some other companies have their products still in the development phase. Medtronic plc. is the only company with FDA approval

Acquisitions, mergers, expansions, product approvals, product launches and adoption of new technologies are the key strategies adopted by manufacturers and integrators for technology transfer and to increase consumer base in different geographies

North America is anticipated to remain the largest consumer base for leadless pacing systems owing to a higher acceptance rate and a favorable reimbursement scenario

Several opportunities are available for companies to improve their product penetration such as development of dual chamber and multi chamber pacing, providing professional education & training, distribution reach etc.

Access Related Reports-

Induced Pluripotent Stem Cells Market: https://www.persistencemarketresearch.com/market-research/induced-pluripotent-stem-cells-market.asp

Europe Cryochambers Market: https://www.persistencemarketresearch.com/market-research/europe-cryochambers-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

This release was published on openPR.